| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 7.545 | 55.021 | 67.970 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | 9.488 | 57.692 | 68.222 | 96 | 1 |
| Total Expenses - EUR | - | - | - | - | - | 35.274 | 113.517 | 346.196 | 8.110 | 7.303 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -25.786 | -55.825 | -277.974 | -8.014 | -7.302 |
| Net Profit/Loss - EUR | - | - | - | - | - | -26.064 | -57.443 | -280.014 | -8.014 | -7.302 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Humans Dna S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 59.343 | 291.470 | 16.761 | 10.719 | 5.199 |
| Current Assets | - | - | - | - | - | 248.572 | 38.281 | 31.868 | 31.668 | 31.491 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 360 | 31.664 | 31.759 | 31.668 | 31.491 |
| Cash | - | - | - | - | - | 248.212 | 6.617 | 109 | 0 | 0 |
| Shareholders Funds | - | - | - | - | - | 305.619 | 241.399 | -37.866 | -45.765 | -52.811 |
| Social Capital | - | - | - | - | - | 2.202 | 2.153 | 2.160 | 2.153 | 2.141 |
| Debts | - | - | - | - | - | 2.295 | 88.353 | 86.495 | 88.153 | 89.501 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5829 - 5829" | |||||||||
| CAEN Financial Year |
5829
|
|||||||||
Comments - Humans Dna S.r.l.